Herbalife (HLF) EBITDA (2009 - 2026)

Herbalife (HLF) has 18 years of EBITDA data on file, last reported at $138.4 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 12.7% year-over-year to $138.4 million; the trailing twelve-month figure through Mar 2026 stood at $496.6 million (up 13.69% YoY), and the FY2025 full-year result was $481.0 million, up 24.64% from the prior year.
• EBITDA grew to $138.4 million in Q1 2026, from $99.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $155.8 million in Q2 2022 to a low of $55.8 million in Q4 2023.
• A 5-year average of $112.2 million and a median of $122.8 million in 2025 frame the typical range for EBITDA.
• Across the five-year window, EBITDA slumped 53.95% in 2023 and soared 90.86% in 2024, its largest moves.
• Tracing HLF's EBITDA over 5 years: stood at $88.9 million in 2022, then slumped by 37.23% to $55.8 million in 2023, then jumped by 90.86% to $106.5 million in 2024, then fell by 6.29% to $99.8 million in 2025, then surged by 38.68% to $138.4 million in 2026.
• Business Quant data shows HLF's EBITDA at $138.4 million in Q1 2026, $99.8 million in Q4 2025, and $125.8 million in Q3 2025.